Search Results - "Peressini, M" :: K.UTB vyhledávací portál

P1.06A.05 Assessing Pathologic Response to Neoadjuvant Chemoimmunotherapy for NSCLC: Aligning Current Protocols with Artificial Intelligence

by Conde, E., Curto, D., Hernandez, S., Alonso, M., Adradas, V., Peressini, M., Paz-Ares, L., Zugazagoitia, J., Lopez-Rios, F.
Published in Journal of thoracic oncology (01.10.2024)

Get full text

Journal Article

Loading…

213 (PB201): MYC Inhibition by OMO-103 Reprograms Tumor Immunity and Enhances Immunotherapy Efficacy in KRAS Mutant NSCLC

by Serra, S. Casacuberta, González-Larreategui, I., Vera, L., Adradas, V., Martínez-Martín, S., Peressini, M., López-Estévez, S., Arnal, M., Sansegundo, L., del Pozo, E. Serrano, Grueso, J., Foradada, L., Thabussot, H., Giuntini, F., Whitfield, J., Beaulieu, M.E., Zugazagoitia, J., Vicent, S., Soucek, L.
Published in European journal of cancer (1990) (01.10.2024)

Get full text

Journal Article

Loading…

164P A spatially informed transcriptomic model to forecast early resistance to front-line osimertinib in advanced EGFR-mutant NSCLC

by Zugazagoitia, J., Ruiz de Garibay, G., Pineda, S., Roch, B., Lopez, P. Garrido, Isla Casado, M.D., Vathiotis, I., Aguado, C., Perez, A. Callejo, Fabregat, R. Marse, Campelo, M.R. García, Cordellat, A. Blasco, Syrigos, K., Caro, R. Bernabe, Vidal, O.J. Juan, Gallego, E. Conde, Fuster, B. Hernando, Macintyre, G., Paz-Ares, L.G., Álvarez, M. Peressini
Published in Annals of oncology (01.09.2024)

Get full text

Journal Article

Loading…

P4.11E.23 Real-World Data (RWD) Of First-Line Cemiplimab Single Agent for Advanced PD-L1 High Expression, Non-Small Cell Lung Cancer (NSCLC)

by Masini, S., Garrido, A., Álvarez, R., Antoñanzas, M., Navarro, F., Traseira, C., Cabezón, L., García, C., Falagan, S., Rocha, P., Mosquera, J., Azkárate, A., García-Lorenzo, E., Martin-Soberón, M.C., Sequero, S., Sereno, M., Lage, Y., Peressini, M., Cortijo, S., Bote, H., Torres-Jiménez, J., Zurera, M., Paz-Ares, L., Zugazagoitia, J., Baena, J.
Published in Journal of thoracic oncology (01.10.2024)

Get full text

Journal Article

Loading…

P1.21-07 Quantitative Assessment of OX40L and Its Association with Sensitivity to First-Line Pembrolizumab in Non-small-Cell Lung Cancer

by Baena, J., Calles, A., Aguado, C., Antoñanzas, M., Lage, Y., Sereno, M., Mielgo, X., Lopez, A., Cervera, R., Cabezón-Gutierrez, L., Rubio, J., Sanchez-Becerra, M.V., Molero-Abraham, M., Peressini, M., Ruiz de Garibay, G., Fernández-Luna, C., Adradas, V., Herrera, M., Cabo, H., Alvarez, R., Garrido, P., Gonzalez-Larriba, J.L., López-Ríos, F., Conde, E., Paz-Ares, L., Zugazagoitia, J.
Published in Journal of thoracic oncology (01.11.2023)

Get full text

Journal Article

Loading…

12P Spatially preserved multi-region transcriptomic subtyping and biomarkers associated with long-term benefit with chemoimmunotherapy in extensive-stage small cell lung cancer (ES-SCLC)

by Peressini, M., Cubells, C. Martí, Calderon, V. Gutierrez, Sureda, B. Massuti, Majem, M., García-Campelo, M.R., Tain, P. Diz, Isla Casado, M.D., Paul, A. Moreno, Navalon, F.J. Garcia, Molero, M., Adradas, V., Gallego, E. Conde, Paz-Ares, L., Zugazagoitia, J.
Published in Immuno-oncology technology (01.12.2023)

Get full text

Journal Article